Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-25 4:47 pm Purchase | 2026-02-18 | 13G | Jasper Therapeutics, Inc. JSPR | Integrated Core Strategies (US) LLC | 1,629,013 5.800% | 1,629,013![]() (New Position) | Filing History |
| 2026-02-18 5:29 pm Purchase | 2026-02-18 | 13D | Jasper Therapeutics, Inc. JSPR | Carlyle Group Inc. CG | 1,088,310 3.800% | 1,088,310![]() (New Position) | Filing History |
| 2026-02-12 10:33 am Purchase | 2025-12-31 | 13G | Jasper Therapeutics, Inc. JSPR | GOLDMAN SACHS GROUP INC GS | 1,764,848 6.300% | 1,764,848![]() (New Position) | Filing History |
| 2026-02-11 1:38 pm Purchase | 2025-12-31 | 13G | Jasper Therapeutics, Inc. JSPR | MORGAN STANLEY MS | 1,969,785 7.000% | 1,185,157![]() (+151.05%) | Filing History |
| 2026-01-26 3:29 pm Sale | 2026-01-23 | 13G | Jasper Therapeutics, Inc. JSPR | ACORN BIOVENTURES, L.P. | 1,486,492 5.300% | -300,000![]() (-16.79%) | Filing History |
| 2025-12-02 10:23 am Purchase | 2025-12-01 | 13G | Jasper Therapeutics, Inc. JSPR | ACORN BIOVENTURES, L.P. | 1,786,492 6.400% | 1,786,492![]() (New Position) | Filing History |
| 2025-11-14 5:22 pm Unchanged | 2025-09-30 | 13G | Jasper Therapeutics, Inc. JSPR | Qiming U.S. Healthcare Fund II, L.P. | 928,964 3.300% | 0 (Unchanged) | Filing History |
| 2025-11-14 12:18 pm Purchase | 2025-09-30 | 13G | Jasper Therapeutics, Inc. JSPR | T. Rowe Price Investment Management, Inc. | 2,057,612 7.100% | 2,057,612![]() (New Position) | Filing History |
| 2025-11-12 1:04 pm Purchase | 2025-09-30 | 13G | Jasper Therapeutics, Inc. JSPR | KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,324,845 4.700% | 559,845![]() (+73.18%) | Filing History |
| 2025-11-07 12:45 pm Purchase | 2025-09-30 | 13G | Jasper Therapeutics, Inc. JSPR | MORGAN STANLEY MS | 784,628 2.800% | 26,175![]() (+3.45%) | Filing History |
| 2025-09-23 5:07 pm Purchase | 2025-09-19 | 13D | Jasper Therapeutics, Inc. JSPR | Velan Capital Investment Management LP | 2,668,395 9.600% | 1,196,492![]() (+81.29%) | Filing History |
| 2025-08-06 4:46 pm Purchase | 2025-06-30 | 13G | Jasper Therapeutics, Inc. JSPR | MORGAN STANLEY MS | 758,453 5.000% | 758,453![]() (New Position) | Filing History |
| 2025-07-17 8:12 pm Sale | 2025-06-30 | 13G | Jasper Therapeutics, Inc. JSPR | BlackRock Inc. BLK | 225,605 1.500% | -574,423![]() (-71.80%) | Filing History |
| 2025-07-11 12:30 pm Purchase | 2025-07-03 | 13G | Jasper Therapeutics, Inc. JSPR | KINGDON CAPITAL MANAGEMENT, L.L.C. | 765,000 5.100% | 765,000![]() (New Position) | Filing History |
| 2025-02-11 4:00 pm Purchase | 2024-12-31 | 13G | Jasper Therapeutics, Inc. JSPR | Soleus Capital Master Fund, L.P. | 1,494,420 9.960% | 507,324![]() (+51.40%) | Filing History |
| 2024-11-14 6:01 pm Sale | 2024-09-30 | 13G | Jasper Therapeutics, Inc. JSPR | Avidity Partners Management LP | 0 0.000% | -760,000![]() (Position Closed) | Filing History |
| 2024-11-14 3:32 pm Purchase | 2024-09-30 | 13G | Jasper Therapeutics, Inc. JSPR | Soleus Private Equity Fund III, L.P. | 1,343,665 9.000% | 1,343,665![]() (New Position) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Jasper Therapeutics, Inc. JSPR | BlackRock Inc. BLK | 800,028 5.300% | 0 (Unchanged) | Filing History |
| 2024-11-04 12:05 pm Purchase | 2024-09-30 | 13G | Jasper Therapeutics, Inc. JSPR | SPHERA FUNDS MANAGEMENT LTD. | 189,270 1.250% | 189,270![]() (New Position) | Filing History |
| 2024-10-22 6:06 pm Purchase | 2024-09-30 | 13G | Jasper Therapeutics, Inc. JSPR | BlackRock Inc. BLK | 800,028 5.300% | 800,028![]() (New Position) | Filing History |

